CASE ON TYPE 2 DIABETIS MELLITUS ,

HYPERTENSION,NEUROPATHY,PSYCHOSIS
 PATIENT DEMOGRAPHIC CHART
 NAME:
 SEX:
 AGE:
 DOA:
 DOD:

 SUBJECTIVE EVIDENCE
 CHEIF COMPLAINTS
 COMPLAINTS OF CHESTPAIN(LEFT SIDE), RADIAING TO THE
BACK SINCE 2 DAYS
 PAST MEDICAL HISTORY
 KNOWN CASE OF TYPE 2 DIABETIS MELLITUS
SINCE 15 YEARS
 KNOWN CASE OF HYPERTENSION, DYSLIPEDMIA
 OBJECTIVE EVIDENCE
VITALS DAY 1 DAY2 DAY3 DAY4 DAY5 DAY6
TEMP 98 97.2 97.8 98 98.4 98
PULSE 98 90 88 98 88 86
RR 18 20 20 22 18 18
BP 142/72 140/70 106/60 120/60 100/90 100/60

pallor icterus cyanosis clubbing lymphadenopathy edema

- - - - - -
 ASSESMENT
 FROM THE ABOVE SUBJECTIVE AND OBJECTIVE EVIDENCE
THE PATIENT WAS DIAGNOSED WITH TYPE 2 DIABETIS
MELLITUS, HYPERTENSION, NEUROPATHY,PSYCHOSIS
 THERAPEUTIC GOAL:
 PATIENT SPECIFIC:
 TO PROVIDE OPTIONAL PHARMACOTHERAPY AND IMPROVE
CONDITION
 DISEASE SPECIFIC:
 TO REDUCE SIGNS AND SYMPTOMS AND IMPROVE PATIENT’S
CONDITION

SLNO Drug name Dose Route Frequency
1 DIPINE 5 mg oral 0-1-0
2 RMIN 500 mg oral 1-0-1
3 DOL+PARACETAMOL 1 tab oral 1-0-1
4 ZOLAM 0.5 mg oral stat
5 VASTATIN 20 mg oral 0-0-1
6 IRIN 75 mg oral 0-1-0
7 ETRON 4 mg i.v s-o-s
8 PRAZOLE 40 mg i.v 0-0-1
9 CETAMOL 100 ml i.v 0-0-1
10 MEPIRIDE 8 mg oral 0-0-1
11 LUS 1 sachet oral 0-0-1
12 LAC 15 ml oral 0-1-1
13 RACIL 100 mg oral 1-0-0
14 LOP 2 mg oral 1-0-0
 DRUG INTERACTIONS MONITORING
SLNO DRUG INTERACTING SEVERITY EFFECTS MANAGEMENT
1 ALPRAZOLAM + MAJOR INCREASED RISK OF AVOID CONCOMITANT
TRAMADOL/PCM RESPIRATORY AND ADMINISTRATION
CNS DEPRESSION

2 ASPIRIN + GLIMIPIRIDE MAJOR HYPOGLYCEMIA AVOID CONCOMITANT

ADMINISTRATION

3 ONDANSETRON + MAJOR INCREASED RISK AVOID CONCOMITANT

RESPIRIDONE OF QT INTERVAL ADMINISTRATION
PROLONGATION
4 ASPIRIN + METFORMIN MAJOR HYPOGLYCEMIA AVOID CONCOMITANT
ADMINISTRATION

5 ONDANSETRON + MAJOR RISK OF TOTALLY AVOID

TRAMADOL/PCM SEROTONIN THIS COMBINATION
SYNDROME
 PLANNING
 PHARMACIST INTERVENTION:
 ACETAMINOPHEN & TRAMADOL+PCM
 DRUG DUPLICATION
 COUNSELLING
 1.DISEASE COUNSELLING:
 HYPERTENSION:
 HYPERTENSION IS ELEVATED ARTERIAL BLOOD PRESSURE ABOVE 120/80 mmHg
 DIABETIS MELLITUS (TYPE 2):
 IT IS CONDITION OF ELEVATED BLOOD SUGAR LEVEL
 NEUROPATHY:
 IS CAUSED BY DIABETIS MELLITUS WHICH IS CHARACTERISED BY WEAKNESS PAIN
AND NUMBNESS
 PSYCHOSIS:
 IT IS ABNORMAL CONDITION OF THE MIND , MENTAL DISORDER EFFECTING
 THINKING ABILITY ,PROBLEM SOLVING ABILITY, SOCIAL LIFE WITHDRAWAL
 etc.
 2.MEDICATION COUNSELLING:
 TAB.AMLOG – IS GIVEN FOR CHEST PAIN
 TAB.GLYCOMET - IS GIVEN FOR CONTROLLING DIABETIS
 TAB.ULTRACET - GIVEN TO REDUCE PAIN
 TAB.ATORVASTATIN – GIVEN FOR CHOLESTEROL CONTROL
 PANTOPRAZOLE – GIVEN TO PREVENT DRUG INDUCED
PEPTIC ULCER
 EMCET – GIVEN TO CONTROL NAUSEA AND VOMITTING
 PATIENT COUNSELLING
 LIFESTYLE MODIFICATION
 FOR HYPERTENSION -
 FOLLOW DASH DIET
 PRACTICE YOGA
 BREATHING EXERCISE AND MORNING WALKS SUGGESTED

 FOR DIABETIS MELLITUS-

 REDUCE THE SUGAR INTAKE IN DIET
 MANAGE WELL BALENCED DIET
 CHECK AND MONITOR BLOOD SUGAR ON REGULAR INTERVALS AND CONSULT
PHYSICIAN

 FOR PSYCHOSIS
 AVOID STRESS
 LAUGHTER THERAPY RECOMMENDED
 YOGA EXERCISES